NCT01214148View on ClinicalTrials.gov

First in Man Experience With a Drug Eluting Stent in De Novo Coronary Artery Lesions

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 31, 2009

Primary Completion Date

April 30, 2010

Study Completion Date

July 31, 2013

Conditions
Coronary Artery Disease
Interventions
DEVICE

ORSIRO - Drug Eluting Coronary Stent

The coronary stent is delivered to the intended implantation location by means of the fast-exchange delivery system and then expanded to its final diameter by dilating the balloon. It remains in the vessel as a permanent implant.

Trial Locations (2)

Unknown

"Institutul de Urgenţă pentru Boli Cardiovasculare Prof. Dr. C. C. Iliescu - Spitalul Clinic Fundeni", Bucharest

Spitalul Clinic de Urgenţă Bucureşti, Bucharest

Sponsors

Lead Sponsor

Biotronik AG
All Listed Sponsors
lead

Biotronik AG

INDUSTRY